BYSI Beyondspring Inc.

BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies.

$2.61  +0.03 (1.16%)
As of 02/01/2023 16:00:01 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  Cayman Islands
IPO date:  03/09/2017
Outstanding shares:  38,928,922
Average volume:  488,905
Market cap:   $99,658,040
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BD36JB9

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%